Collagenex, Mutual Settle Patent Suit Over Periodontitis Treatment
CollaGenex Pharmaceuticals has settled its patent litigation against Mutual Pharmaceuticals over a treatment for adult periodontitis, in an agreement that includes a licensing agreement and a $2 million payment to Mutual....To view the full article, register now.
Already a subscriber? Click here to view full article